TickerFactsScreenerDevelopers

NEKTAR THERAPEUTICS (NKTR) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $30.21M2017: $30.55M2018: $24.41M2019: $21.37M2020: $19.48M2021: $24.90M2022: $21.64M2023: $33.77M2024: $30.69M2025: $0$0
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$0-100.0%
2024$30.69M-9.1%
2023$33.77M+56.1%
2022$21.64M-13.1%
2021$24.90M+27.8%
2020$19.48M-8.9%
2019$21.37M-12.4%
2018$24.41M-20.1%
2017$30.55M+1.1%
2016$30.21M—